MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superb biomarker to detect diseases earlier. Our test can be used in continuous testing both for preventative screening and post-treatment monitoring.
Artificial Intelligence, Bioinformatics, Health Care
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as MultiplAI Health? We’re happy to assist you with our Startup Sourcing service.